Table 3 Prevalence (± CI 95 ) of trypanosome infections at the five different study locations
Location | Individuals sampled | Uninfected individuals | T. vegrandis | T. copemani | T. sp. H25 | T. vegrandis & T. copemani | T. vegrandis & T. sp. H25 |
|---|---|---|---|---|---|---|---|
NAR | 45 | 55.6% (48.1 – 63.0) | 0% | 33.3% (26.2 – 40.4) | 0% | 11.1% (6.4 – 15.85) | 0% |
KP* | 43 | 93.0% (89.1 – 97.0) | 0% | 4.7% (1.4 – 7.9) | 2.3% (0.0 – 4.7) | 0% | 0% |
PP* | 86 | 53.5% (48.1 – 58.9) | 1.1% (0.0 – 2.3) | 25.6% (20.8 – 30.3) | 0% | 19.8% (15.4 – 24.1) | 0% |
PS | 70 | 71.4% (66.0 – 76.9) | 2.9% (0.9 –4.9) | 18.5% (13.9 – 23.3) | 4.3% (1.8 –6.7) | 2.9% (0.9 –4.9) | 0% |
KWS | 67 | 22.4% (17.3 – 27.5) | 64.2% (58.3 – 70.1) | 0% | 0% | 8.9% (5.4 – 12.5) | 4.5% (1.9 – 7.0) |